TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma

Telomerase reverse transcriptase (TERT) activity is up-regulated in several types of tumors including glioblastoma (GBM). In the present study, 128 primary glioblastoma patients were examined for single nucleotide polymorphisms of TERT in blood and in 92 cases for TERT promoter mutations in tumors....

Descripción completa

Detalles Bibliográficos
Autores principales: Mosrati, Mohamed Ali, Malmström, Annika, Lysiak, Malgorzata, Krysztofiak, Adam, Hallbeck, Martin, Milos, Peter, Hallbeck, Anna-Lotta, Bratthäll, Charlotte, Strandéus, Michael, Stenmark-Askmalm, Marie, Söderkvist, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599297/
https://www.ncbi.nlm.nih.gov/pubmed/26143636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599297/
https://www.ncbi.nlm.nih.gov/pubmed/26143636

Ejemplares similares